Sign in

CIK 0000771856

  • Non-accelerated filer
  • Smaller reporting company

CHAMPIONS ONCOLOGY, INC.

Sign in to watch
Ticker
CSBR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Apr 30
Incorporated
DE
Entity type
Operating
EIN
521401755
Phone
+1 410-369-0365
Business address
855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
Former names
CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy President bought 30,000 shares at an average $1.66 ($49,900)
  10. 4 Open-market buy President bought 10,000 shares at $1.70 ($17,000)
  11. 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $1.70 ($3,393)
  12. 4 Open-market buy President bought 10,305 shares at $1.66 ($17,106)
  13. 4 Open-market buy Chief Executive Officer bought 7,300 shares at an average $1.67 ($12,205)
  14. 4 Open-market buy President bought 29,695 shares at an average $1.67 ($49,494)
  15. 4 Open-market buy President bought 9,537 shares at $1.66 ($15,831)
  16. 4 Open-market buy Chief Executive Officer bought 8,202 shares at an average $1.63 ($13,369)
  17. 4 Open-market buy Chief Executive Officer bought 33 shares at $1.65 ($54)
  18. 4 Open-market buy President bought 3,000 shares at $1.58 ($4,740)
  19. 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $1.66 ($8,324)
  20. 4/A Derivatives Options or other derivatives

Page 7 of 13 · 245 filings